Arranta Bio
Arranta Bio LLC is a contract development and manufacturing organization specializing in the development and production of live biopharmaceutical products, particularly those targeting human microbiome-related diseases. Founded in 2019 and headquartered in Watertown, Massachusetts, the company offers a comprehensive range of services, including media formulation, cell banking, fermentation, lyophilization, and analytical services, all conducted under current Good Manufacturing Practices (cGMP). Arranta Bio operates a process development and cGMP manufacturing facility in Gainesville, Florida, where it focuses on bacterial fermentation, isolation, drying, and encapsulation processes for live biotherapeutic products. The company aims to support innovators in the healthcare sector in bringing effective treatments to market through its advanced manufacturing capabilities.
Top Stages
2 past transactions
Thymmune Therapeutics
Seed Round in 2023
Thymmune Therapeutics is a biotechnology company developing a machine learning-driven thymic cell engineering platform to restore normal immune function in aging and disease.
Captozyme
Acquisition in 2019
Captozyme Inc. is a biotechnology company based in Gainesville, Florida, that specializes in the development of oxalate-degrading enzyme therapeutics. Founded in 2016, the company focuses on removing non-nutrient oxalate from the diet and body of patients, particularly those suffering from kidney stones and certain orphan disorders. Captozyme's flagship product, Nephure, was designed to enable individuals to enjoy a wider variety of foods without the adverse effects associated with oxalate consumption. Through innovative research and a commitment to scientific excellence, Captozyme aims to enhance dietary management and overall health for its patients. As of November 2019, Captozyme operates as a subsidiary of Arranta Bio LLC.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.